Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-002823
Filing Date
2025-01-07
Accepted
2025-01-07 16:05:03
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3432
  Complete submission text file 0000950170-25-002823.txt   4928
Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Issuer) CIK: 0001534969 (see all company filings)

IRS No.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 2 MERCER ROAD NATICK MA 01760
Business Address
Mirza Mansoor Raza (Reporting) CIK: 0001588389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40606 | Film No.: 25514875